Following an abbreviated submission
risperidone 3mg, 4mg orodispersible tablets (Risperdal Quicklet®) are accepted for restricted use within NHS Scotland for treatment of acute and chronic schizophrenia and similar psychosis and treatment of mania in bipolar disorder.
These new strengths of risperidone orodispersible tablets should be used in patients for whom risperidone is an appropriate choice of antipsychotic and an orodispersible tablet is an appropriate formulation.
Download detailed advice24KB (PDF)
- Medicine name:
- risperidone 3mg 4mg orodispersible tablets (Risperdal Quicklet)
- SMC ID:
- for treatment of acute and chronic schizophrenia and similar psychosis and treatment of mania in bipolar disorder
- Pharmaceutical company
- Janssen-Cilag Ltd
- BNF chapter
- Central nervous system
- Submission type
- Date advice published
- 10 September 2007